Paulson & Co. - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 120 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
Paulson & Co. ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2017$1,807,000
-0.8%
662,056
+20.4%
0.02%0.0%
Q1 2017$1,821,000
+97.3%
550,000
+41.9%
0.02%
+100.0%
Q4 2016$923,000
-68.8%
387,697
-51.8%
0.01%
-62.5%
Q3 2016$2,954,000
+32.5%
805,000
-19.5%
0.03%
+39.1%
Q2 2016$2,229,000
+7.2%
999,7000.0%0.02%
+53.3%
Q1 2016$2,079,000
+29.8%
999,700
+89.1%
0.02%
+50.0%
Q4 2015$1,602,000528,7000.01%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,847,087$4,119,0003.26%
Sio Capital Management, LLC 1,333,696$2,974,0001.52%
Boxer Capital, LLC 700,000$1,561,0001.38%
Palo Alto Investors LP 5,386,534$12,012,0000.91%
ACUTA CAPITAL PARTNERS, LLC 747,748$1,667,0000.80%
SENZAR ASSET MANAGEMENT, LLC 1,443,003$3,217,897,0000.70%
Ghost Tree Capital, LLC 800,000$1,784,0000.52%
NEA Management Company, LLC 3,243,150$7,232,0000.38%
Rhenman & Partners Asset Management AB 850,000$1,896,0000.34%
Rock Springs Capital Management LP 1,750,000$3,903,0000.29%
View complete list of RIGEL PHARMACEUTICALS INC shareholders